Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK7791 Phosphate Binder Switch Study in Hemodialysis
NCT04771780Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in hyperphosphatemia, sponsored by Kyowa Kirin. Started Mar 2021; status: completed.
02
Drugs
tenapanor
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT04771780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771780.